- Home
- GSK vs NU Comparison
GSK vs NU Comparison
Compare GSK & NU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$58.88
Company Overview
Basic Information| Metric | GSK | NU |
|---|---|---|
| Founded | 1715 | 2013 |
| Country | United Kingdom | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.1B | 77.0B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GSK | NU |
|---|---|---|
| Price | $58.88 | $16.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | N/A | ★ $17.93 |
| AVG Volume (30 Days) | 6.9M | ★ 53.5M |
| Earning Date | 02-04-2026 | 02-25-2026 |
| Dividend Yield | ★ 2.84% | N/A |
| EPS Growth | ★ 123.15 | 41.55 |
| EPS | ★ 1.87 | 0.52 |
| Revenue | ★ $43,966,352,618.00 | $6,360,698,000.00 |
| Revenue This Year | $7.72 | $158.14 |
| Revenue Next Year | $4.59 | $32.83 |
| P/E Ratio | ★ $31.55 | $32.61 |
| Revenue Growth | 4.12 | ★ 20.40 |
| 52 Week Low | $32.38 | $9.01 |
| 52 Week High | $60.37 | $18.98 |
Technical Indicators
Market Signals| Indicator | GSK | NU |
|---|---|---|
| Relative Strength Index (RSI) | 74.38 | 42.72 |
| Support Level | $58.02 | $17.04 |
| Resistance Level | $60.37 | $17.99 |
| Average True Range (ATR) | 0.95 | 0.70 |
| MACD | 0.53 | -0.14 |
| Stochastic Oscillator | 86.64 | 17.24 |
Price Performance
Historical Comparison GSK
NU
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About NU Nu Holdings Ltd.
Nu Holdings Ltd provides digital banking services. It offers several financial services such as Credit cards, Personal accounts, Investments, Personal Loans, Insurance, Mobile payments, Business Accounts, and Rewards. The company earns the majority of its revenue in Brazil.